Tel Aviv [Israel], September 18 (ANI/TPS): Israeli ag-biotech firm PlantArcBio announced Thursday that it has secured patents in the United States and South Korea for its DIPPER platform, which optimises gene-editing processes in crops.
The Tel Aviv-based company said the technology enhances the precision and efficiency of tools like CRISPR, accelerating the development of traits such as drought tolerance, yield improvement, and herbicide resistance.
CEO Dror Shalitin called DIPPER a “game-changing platform” that can shorten commercialisation timelines and boost global food security. (ANI/TPS)
The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.
Nov 4 (Reuters) - Strategy Inc: * STRATEGY: MAY OFFER, SELL SHARES OF VARIABLE RATE…
(Reuters) -Shares of iHeartMedia hit their highest in more than two years on Tuesday after…
Los Angeles (dpa) - Researchers at the Mayo Clinic in the United States say they…
By Akash Sriram (Reuters) -Uber missed operating profit expectations on Tuesday and issued a downbeat…
By Lawrence White LONDON (Reuters) -Starling Group has signed a 10-year agreement to upgrade core…
(Reuters) -Activist investor Kimmeridge on Tuesday called for an overhaul of leadership and strategy at…